Advertisement

Topics

Antikor Biopharma Limited Company Profile

21:17 EDT 19th April 2018 | BioPortfolio


News Articles [1537 Associated News Articles listed on BioPortfolio]

Antikor Advances Breakthrough Fragment Drug Conjugate (FDC) Technology Demonstrating Superior ...

Antikor Biopharma LimitedDr Mahendra DeonarainCEOm.deonarain@antikor.co.uk Read more...

Antikor Takes Aim At Solid Tumors With Antibody-Fragment Conjugates

Emerging Company Profile: The UK's Antikor Biopharma is advancing antibody fragment-drug conjugates (FDCs) closer to the clinic with plans for...  

Antikor Advances Breakthrough Fragment Drug Conjugate (FDC) Technology Demonstrating Superior Penetration and Tolerability

Antikor Biopharma Limited (Antikor), a leader in developing and advancing Antibody Fragment-Drug Conjugates (FDCs), will be presenting new data at the 9th Protein and Antibody Eng...

PDL BioPharma: Buy or Sell

It’s not unusual for a biopharma company, given enough time, to have its ups and downs. But PDL BioPharma’s roller-coaster ride has been more dramatic than most.

BioPharma Ambition 2018: Live updates from an all-island event

In between NIBRT site tours and tax workshops in Dublin Castle, Biopharma-Reporter is covering BioPharma Ambition on the Emerald Isle.

#jobs #lifescience Biopharma/Biotech

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Biopharma/Biotech .CA-South San Francisco, Biopharma/Biotech Company: Amgen, ...

BioPharma Dive's 3 predictions for 2018 and beyond

What trends will shape the biopharma industry in 2018? BioPharma Dive's editors took a stab at predicting how the year may unfold for AI, oncology and neuroscience.

ARRAY BIOPHARMA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Array Biopharma, Inc. To Contact The Firm

NEW YORK, NY / ACCESSWIRE / January 11, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Array Biopharma, Inc. ("Array Biopharma" or the "Company") (NASDAQ:...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

The positive impacts of Real-World Data on the challenges facing the evolution of biopharma.

Demand for healthcare services is unprecedented. Society is struggling to afford the cost. Pricing of biopharmaceutical products is under scrutiny, especially by payers and Health Technology Assessmen...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Single Ascending Dose Phase 1 Trial in Patients With Type 2 Diabetes

ARRY-403 is an investigational new drug being developed by Array BioPharma Inc. for treating Type 2 diabetes. The purpose of this study is to test the safety (potential side effects) and ...

A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis

The process of re-narrowing of a coronary artery following a revascularization procedure such as angioplasty, begins at the time of the procedure. Restenosis has long been considered a ma...

Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries

The process of re-narrowing of a coronary artery following a revascularization procedure such as angioplasty, begins at the time of the procedure. Restenosis has long been considered a ma...

Companies [211 Associated Companies listed on BioPortfolio]

Antikor Biopharma Limited

SAFE-BioPharma Association

SAFE-BioPharma Association (www.safe-biopharma.org) is the non-profit association that created and manages the SAFE-BioPharma® digital identity and signature standard for the ...

Genesis Biopharma, Inc.

Genesis Biopharma, Inc. is a development-stage biotechnology company engaged primarily in the development of targeted cancer therapies. For more information on the Company, visit http://www.genesis-b...

TenX Biopharma, Inc.

TenX Biopharma, Inc., is a biopharmaceutical company focused on late stage development and commercialization of novel monoclonal antibody-based cancer therapies. TenX Biopharma acquired global rights ...

Rentschler Biopharma SE

Rentschler Biopharma SE, located in Laupheim, Germany, is a leading contract development and manufacturing organization (CDMO) for bioprocess development and manufacturing of biop...

More Information about "Antikor Biopharma Limited" on BioPortfolio

We have published hundreds of Antikor Biopharma Limited news stories on BioPortfolio along with dozens of Antikor Biopharma Limited Clinical Trials and PubMed Articles about Antikor Biopharma Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Antikor Biopharma Limited Companies in our database. You can also find out about relevant Antikor Biopharma Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record